Business Standard

India sees most number of cervical cancer cases, deaths in Asia: Lancet

Lancet report titled, "Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative," highlights glaring reality

HPV vaccines are now available in the range of Rs 2,000-3,500 per dose. (Photo: ANI)
Premium

HPV vaccines

Nupur Dogra New Delhi
According to the latest Lancet report, more than 58 per cent of all cases of cervical cancer globally were estimated in Asia followed by Africa (20 per cent), Europe (10 per cent) and Latin America (10 per cent). The latest report titled, "Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative," highlights glaring reality of cervical cancer in world. 

As Asia reported the maximum number of cases across the world, India recoded the most number of cases and deaths due to cervical cancer among its Asian peers.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in